Funds will help boost marketing with an immediate focus on growing the U.S. business. Neo Medical focuses on thoracolumbar fusion, and its Advise AR platform leverages artificial intelligence.
Neo Medical’s technologies can reduce implant failure rates by up to three times, cut infection risk by half and cut time spent in surgery by up to 29%, according to studies.
Gyrus Capital led the funding round, along with existing investors.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.